(1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol
CAS501-33-7
(1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol (CAS 501-33-7, C7H13NO) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 501-33-7
- Formula
- C7H13NO
- Mol. weight
- 127.19 g/mol
Chemical Specifications
Identifiers
| CAS number | 501-33-7 |
|---|---|
| Product name | (1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol |
| Synonyms | (1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol; Pseudonortropine; Pseudotropigenine; Exo-3-hydroxy-8-azabicyclo[3.2.1]octane |
| Molecular formula | C7H13NO |
| Molecular weight | 127.19 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of (1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol?
The CAS Registry Number of (1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol is 501-33-7. (1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol is also known as (1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol; Pseudonortropine; Pseudotropigenine.
What is the molecular formula and molecular weight of (1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol?
The molecular formula of (1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol is C7H13NO, and its molecular weight is 127.19 g/mol.
How can I request a quotation for (1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol?
Send an inquiry for (1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol (CAS 501-33-7) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for (1α,5α)-8-Azabicyclo[3.2.1]octane-3α-ol
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.